Published 2 days ago • loading... • Updated 2 days ago

Biotech Firm Odyssey Raises $279 Million in Upsized US IPO

Summary by WBOC 16

BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (“Odyssey”), a clinical-stage biopharmaceutical

9 Articles

Reuters

Center

Biotech firm Odyssey raises $279 million in upsized US IPO

2 days ago·United Kingdom

Read Full Article

biopharmadive.com

Center

Odyssey, on second try, snags $279M in an IPO

After withdrawing its initial filing last year, the immune drugmaker rebounded and added to a recent run of sizable new biotech stock offerings.

2 days ago

Read Full Article

WBOC 16

+5 Reposted by 5 other sources

Center

Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering

BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (“Odyssey”), a clinical-stage biopharmaceutical

2 days ago

Read Full Article

GeneOnline News

Odyssey Therapeutics IPO Prices at $27 per Share, Aims to Raise $305.1 Million

Odyssey Therapeutics recently announced the pricing of […] The post Odyssey Therapeutics IPO Prices at $27 per Share, Aims to Raise $305.1 Million first appeared on GeneOnline News. The post Odyssey Therapeutics IPO Prices at $27 per Share, Aims to Raise $305.1 Million appeared first on GeneOnline News.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year